InspireMD (NSPR) PT Lowered to $4 but Piper Sandler Sees 'Opportunity for Significant Value Creation'
Tweet Send to a Friend
Piper Sandler analyst Adam Maeder lowered the price target on InspireMD (NASDAQ: NSPR) to $4.00 (from $4.50) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
